Federal Register / Vol. 85, No. 242 / Wednesday, December 16, 2020 / Notices 81479 

Dated: December 10, 2020. 

Marquita Cullom, 

Associate Director. 

[FR Doc. 2020–27589 Filed 12–15–20; 8:45 am] 

BILLING CODE 4160–90–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Office of the Secretary 

Delegation of Authority 

Notice is hereby given that I have 

delegated to the National Coordinator 

for Health Information Technology, 

Office of the National Coordinator for 

Health Information Technology (ONC), 

or his or her successor, the authorities 

that are vested in the Secretary of Health 

and Human Services under title III, 

Section 307, ‘‘International 

Cooperation,’’ of the Public Health 

Service (PHS) Act, [42 U.S.C. 242 l], as 

amended, with regard to participating 

with other countries in cooperative 

endeavors. 

Limitation 

This delegation of authority may be 

re-delegated within ONC. Previous 

delegations and re-delegations made to 

officials within the Department of 

Health and Human Services for 

authorities under Section 307 of the 

PHS Act continue in effect. Exercise of 

this authority shall be in accordance 

with established policies, procedures, 

guidelines, and regulations as 

prescribed by the Secretary. The 

Secretary retains the authority to submit 

reports to Congress, promulgate 

regulations, and to establish advisory 

committees and councils and appoint 

their members. I hereby affirm and ratify 

any actions taken by the National 

Coordinator, ONC, or other ONC 

officials, which involve the exercise of 

this authority prior to the effective date 

of this delegation. 

Effective Date 

This delegation of authority is 

effective immediately. 

Authority 

Section 6 of the Reorganization Plan 

No. 1 of 1953 and Section 2 of the 

Reorganization Plan No. 3 of 1966. 

Dated: December 9, 2020. 

Eric D. Hargan, 

Deputy Secretary. 

[FR Doc. 2020–27606 Filed 12–15–20; 8:45 am] 

BILLING CODE 4150–45–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Cancer Institute; Notice of 

Closed Meetings 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications 

and/or contract proposals and the 

discussions could disclose confidential 

trade secrets or commercial property 

such as patentable material, and 

personal information concerning 

individuals associated with the grant 

applications and/or contract proposals, 

the disclosure of which would 

constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Cancer 

Institute Special Emphasis Panel; K22 

Transition Career Development Award. 

Date: January 19, 2021. 

Time: 10:00 a.m. to 7:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Cancer Institute at Shady 

Grove, 9609 Medical Center Drive, Room 

7W234, Rockville, Maryland 20850 

(Telephone Conference Call). 

Contact Person: Adriana Stoica, Ph.D., 

Scientific Review Officer, Resources and 

Training Review Branch, Division of 

Extramural Activities, National Cancer 

Institute, NIH, 9609 Medical Center Drive, 

Room 7W234, Rockville, Maryland 20850, 

240–276–6368, Stoicaa2@mail.nih.gov. 

Name of Committee: National Cancer 

Institute Special Emphasis Panel; Assay 

Validation of High-Quality Markers for 

Clinical Studies in Cancer. 

Date: January 21, 2021. 

Time: 1:30 p.m. to 3:30 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Cancer Institute at Shady 

Grove, 9609 Medical Center Drive, Room 

7W124, Rockville, Maryland 20850 

(Telephone Conference Call). 

Contact Person: Eun Ah Cho, Ph.D., 

Scientific Review Officer, Special Review 

Branch, Division of Extramural Activities, 

National Cancer Institute, NIH, 9609 Medical 

Center Drive, Room 7W124, Rockville, 

Maryland 20850, 240–276–6342 choe@

mail.nih.gov. 

Name of Committee: National Cancer 

Institute Special Emphasis Panel; 

Applications related to Pediatrics. 

Date: January 26, 2021. 

Time: 10:00 a.m. to 5:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Cancer Institute at Shady 

Grove, 9609 Medical Center Drive, Room 

7W530, Rockville, Maryland 20850, 

(Telephone Conference Call). 

Contact Person: Shamala K. Srinivas, 

Ph.D., Associate Director, Office of Referral, 

Review, and Program Coordination, Division 

of Extramural Activities, National Cancer 

Institute, NIH, 9609 Medical Center Drive, 

Room 7W530, Rockville, Maryland 20850, 

240–276–6442 ss537t@nih.gov. 

Name of Committee: National Cancer 

Institute Special Emphasis Panel; TEP–3: 

SBIR Contract Review. 

Date: January 29, 2021. 

Time: 10:00 a.m. to 6:00 p.m. 

Agenda: To review and evaluate contract 

proposals. 

Place: National Cancer Institute at Shady 

Grove, 9609 Medical Center Drive, Room 

7W254, Rockville, Maryland 20850, 

(Telephone Conference Call). 

Contact Person: Eduardo Emilio Chufan, 

Ph.D., Scientific Review Officer, Research 

Technology and Contract Review Branch, 

Division of Extramural Activities, National 

Cancer Institute, NIH, 9609 Medical Center 

Drive, Room 7W254, Rockville, Maryland 

20850, 240–276–7975 chufanee@

mail.nih.gov. 

Name of Committee: National Cancer 

Institute Special Emphasis Panel; SEP–5: NCI 

Clinical and Translational R21 and Omnibus 

R03 Review. 

Date: February 4–5, 2021. 

Time: 9:00 a.m. to 5:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Cancer Institute at Shady 

Grove, 9609 Medical Center Drive, Room 

7W248, Rockville, Maryland 20850, 

(Telephone Conference Call). 

Contact Person: Shree Ram Singh, Ph.D., 

Scientific Review Officer, Special Review 

Branch, Division of Extramural Activities, 

National Cancer Institute, NIH, 9609 Medical 

Center Drive, Room 7W248, Rockville, 

Maryland 20817, 240–672–6175 singhshr@

mail.nih.gov. 

Name of Committee: National Cancer 

Institute Special Emphasis Panel; SEP–2: NCI 

Clinical and Translational R21 and Omnibus 

R03 Review. 

Date: February 4–5, 2021. 

Time: 10:00 a.m. to 6:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Cancer Institute at Shady 

Grove, 9609 Medical Center Drive, Room 

7W264, Rockville, Maryland 20850 

(Telephone Conference Call) 

Contact Person: Ombretta Salvucci, Ph.D., 

Scientific Review Officer, Special Review 

Branch, Division of Extramural Activities, 

National Cancer Institute, NIH, 9609 Medical 

Center Drive, Room 7W264, Rockville, 

Maryland 20854, 240–276–7286 salvucco@

mail.nih.gov. 

Name of Committee: National Cancer 

Institute Special Emphasis Panel; NCI SPORE 

(P50) Review IV. 

Date: February 9–10, 2021. 

Time: 9:00 a.m. to 5:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Cancer Institute at Shady 

Grove, 9609 Medical Center Drive, Room 


khammond on DSKJM1Z7X2PROD with NOTICES